Friday, November 20, 2026
HomeHealthcareRemidio and KIDROP secure CDSCO approval for AI-based ROP screening

Remidio and KIDROP secure CDSCO approval for AI-based ROP screening

Bengaluru, November 20, 2026: Remidio Innovative Solutions has received approval from India’s Central Drugs Standard Control Organisation (CDSCO) for its MediosHI ROP AI, making it the world’s first regulator-approved artificial intelligence solution for retinopathy of prematurity (ROP) screening. The AI tool was developed in collaboration with Narayana Nethralaya Eye Institute’s KIDROP programme.

ROP is a leading cause of preventable childhood blindness, and India, with an estimated 3.02 million premature births in 2020, faces a significant challenge in screening at-risk infants. The country has fewer than 300 ROP specialists, with most concentrated in major cities, leaving many neonatal units underserved.

AI-enabled bedside screening

The MediosHI ROP AI operates offline and is device-agnostic, capable of analysing retinal images from Remidio’s Insta Neubo 130 and other ROP cameras. Trained nurses or technicians can capture retinal images at the bedside, receive immediate AI analysis, and flag cases needing specialist review. Ophthalmologists then remotely assess the images and determine the next steps, allowing screening to reach neonatal units that specialists seldom visit.

According to Remidio, the AI did not miss any cases of type 1 ROP—the severe form requiring urgent treatment—during clinical testing. In a study involving 600 infants imaged on multiple ROP cameras, the AI demonstrated 91% sensitivity in detecting any stage of ROP and 87% specificity in identifying unaffected babies, based on diagnoses agreed by a panel of ROP specialists.

Addressing specialist shortages

India’s shortage of ROP specialists means each is responsible for thousands of babies annually. In a 2017 study of four district newborn units, only 18% of eligible infants were screened even once. The AI system aims to prioritise cases for specialist attention, ensuring timely intervention and reducing the risk of blindness due to missed or delayed screening.

Dr. Anand Sivaraman, Chief Executive Officer of Remidio, said the technology enables screening to become standard in every neonatal unit, regardless of specialist availability. Dr. Divya Rao, Chief Medical Officer and Medical Director at Remidio, emphasised that the AI prioritises cases while clinical decisions remain with ophthalmologists.

Development and telemedicine integration

MediosHI ROP AI was developed using KIDROP’s extensive bank of labelled retinal images, with funding from the Biotechnology Industry Research Assistance Council (BIRAC). KIDROP, India’s first tele-ROP programme, has expanded from three centres in Karnataka to 177, screening over 115,000 premature babies and providing more than 6,500 treatments since 2008.

The AI integrates with the tele-ROP model pioneered by KIDROP, where nurses or technicians capture retinal images, the AI analyses them offline, and specialists review flagged cases remotely. This workflow allows a single specialist to support multiple neonatal units efficiently.

Regulatory and clinical significance

Sundeep Agarwal, Senior Vice President, Quality Assurance and Regulatory Affairs at Remidio, described the CDSCO approval as a milestone in responsible AI adoption in healthcare, noting that the software’s intended purpose and scope are clearly defined within the ROP triage workflow.

Dr. Anand Vinekar, Founder and Program Director of KIDROP and Head of the Department of Pediatric Retina at Narayana Nethralaya Eye Institute, highlighted that standardised imaging and AI triage can help expand ROP screening to every baby in need, regardless of location.


Disclaimer: This article is based on a press release provided by the concerned organisation and has been edited for style and clarity with the assistance of AI tools. BusinessFortnight does not verify, endorse, or take responsibility for the claims, figures, or statements made in the original release.

Ravindra Soni
Ravindra Sonihttps://businessfortnight.com
Senior journalist with 38 years of experience in print and digital media. Former Executive Editor. Founder and Editor of BusinessFortnight, covering business, economy, and policy news from Madhya Pradesh and across India.
RELATED ARTICLES

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Most Popular

Recent Comments